X. Chen, “Influence of ESG Performance on Stock Repurchase Decision of the Pharmaceutical and Biological Industry”, ESG, vol. 3, no. 1, pp. 1–9, Jan. 2026, doi: 10.70267/esg2026.v3n1.0109.